Arthritis of the first metatarsophalangeal joint is not always gout: A prospective cohort study in primary care patients

Joint Bone Spine

Volumn 81, Issue 4, 2014, Pages 342-346

  Kienhorst, Laura B E ^a   Janssens, Hein J E M ^a,b   Fransen, Jaap ^b   van de Lisdonk, Eloy H ^b   Janssen, Matthijs ^a  

^a RIJNSTATE HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Arthritis; First metatarsophalangeal joint; Gout; Monosodium urate crystals; Synovial fluid

Indexed keywords

URATE; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CREATININE; DIURETIC AGENT;

ADULT; ARTICLE; COXITIS; CRYSTAL; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; GOUT; HUMAN; MAJOR CLINICAL STUDY; MALE; METATARSOPHALANGEAL JOINT; MONARTHRITIS; PATIENT CODING; PREDICTIVE VALUE; PREVALENCE; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; RHEUMATIC DISEASE; RHEUMATOLOGY; SYNOVIAL FLUID; VALIDITY; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; GLOMERULUS FILTRATION RATE; HYPERTENSION; MIDDLE AGED; OSTEOARTHRITIS; SENSITIVITY AND SPECIFICITY; URIC ACID BLOOD LEVEL; VISUAL ANALOG SCALE;

ARTHRITIS; FIRST METATARSOPHALANGEAL JOINT; GOUT; MONOSODIUM URATE-CRYSTALS; SYNOVIAL FLUID;

AGED; ARTHRITIS; FEMALE; GOUT; HUMANS; MALE; METATARSOPHALANGEAL JOINT; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; RHEUMATIC DISEASES; SYNOVIAL FLUID; URIC ACID;

EID: 84904125781     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.12.001     Document Type: Article

References (40)

1. Nuki G., Simkin P.A. A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther 2006, 8:S1.
2. Janssens H.J., Fransen J., van de Lisdonk E.H., et al. A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis. Arch Intern Med 2010, 170:1120-1126.
3. Annemans L., Spaepen E., Gaskin M., et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 2008, 67:960-966.
4. Roddy E. Revisiting the pathogenesis of podagra: why does gout target the foot?. J Foot Ankle Res 2011, 4:13.
5. Grahame R., Scott J.T. Clinical survey of 354 patients with gout. Ann Rheum Dis 1970, 29:461-468.
6. Choi H.K., Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007, 116:894-900.
7. Krishnan E., Svendsen K., Neaton J.D., et al. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008, 168:1104-1110.
8. Kuo C.F., See L.C., Luo S.F., et al. Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology (Oxford) 2010, 49:141-146.
9. Byng-Maddick R., Jeyalingam L., Keat A. Management of persistent inflammatory large joint monoarthritis. Clin Rheumatol 2012, 31:1657-1662.
10. Ma L., Cranney A., Holroyd-Leduc J.M. Acute monoarthritis: what is the cause of my patient's painful swollen joint?. CMAJ 2009, 180:59-65.
11. Binard A., Alassane S., Devauchelle-Pensec V., et al. Outcome of early monoarthritis: a follow-up study. J Rheumatol 2007, 34:2351-2357.
12. Siva C., Velazquez C., Mody A., et al. Diagnosing acute monoarthritis in adults: a practical approach for the family physician. Am Fam Physician 2003, 68:83-90.
13. Cibere J. Rheumatology: 4. Acute monoarthritis. CMAJ 2000, 162:1577-1583.
14. Bailey J.P., Rahn D.W. Acute monarthritis. Bull Rheum Dis 1997, 46:1-2.
15. Freed J.F., Nies K.M., Boyer R.S., et al. Acute monoarticular arthritis. A diagnostic approach. JAMA 1980, 243:2314-2316.
16. Maury E.E., Flores R.H. Acute monarthritis: diagnosis and management. Prim Care 2006, 33:779-793.
17. Sack K. Monarthritis: differential diagnosis. Am J Med 1997, 102:30S-34S.
18. Baker D.G., Schumacher H.R. Acute monoarthritis. N Engl J Med 1993, 329:1013-1020.
19. Pitkeathly D.A., Griffiths H.E., Catto M. Monarthritis. A study of forty-five cases. J Bone Joint Surg Br 1964, 46:685-696.
20. Blocka K.L., Sibley J.T. Undiagnosed chronic monarthritis. Clinical and evolutionary profile. Arthritis Rheum 1987, 30:1357-1361.
21. Fam A.G., Rubenstein J. Hydroxyapatite pseudopodagra. A syndrome of young women. Arthritis Rheum 1989, 32:741-747.
22. Hoffman G.S., Schumacher H.R., Paul H., et al. Calcium oxalate microcrystalline-associated arthritis in end-stage renal disease. Ann Intern Med 1982, 97:36-42.
23. Iagnocco A., Rizzo C., Gattamelata A., et al. Osteoarthritis of the foot: a review of the current state of knowledge. Med Ultrason 2013, 15:35-40.
24. Mines D., Abbuhl S.B. Hydroxyapatite pseudopodagra in a young man: acute calcific periarthritis of the first metatarsophalangeal joint. Am J Emerg Med 1996, 14:180-182.
25. Schumacher H.R., Smolyo A.P., Tse R.L., et al. Arthritis associated with apatite crystals. Ann Intern Med 1977, 87:411-416.
26. Swannell A.J., Underwood F.A., Dixon A.S. Periarticular calcific deposits mimicking acute arthritis. Ann Rheum Dis 1970, 29:380-385.
27. Nissi R., Perhomaa M., Silvennoinen L., et al. Hereditary isolated metatarsophalangeal arthritis. Scand J Rheumatol 2011, 40:22-25.
28. Bomalaski J.S., Schumacher H.R. Podagra is more than gout. Bull Rheum Dis 1984, 34:1-8.
29. Huskisson E.C., Balme H.W. Pseudopodagra. Differential diagnosis of gout. Lancet 1972, 2:269-271.
30. Velilla-Moliner J., Martinez-Burgui J.A., Cobeta-Garca J.C., et al. Podagra, is it always gout?. Am J Emerg Med 2004, 22:320-321.
31. Wallace S.L., Robinson H., Masi A.T., et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977, 20:895-900.
32. Weinfeld S.B., Schon L.C. Hallux metatarsophalangeal arthritis. Clin Orthop Relat Res 1998, 349:9-19.
33. Savolainen E., Kaipiainen-Seppanen O., Kroger L., et al. Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J Rheumatol 2003, 30:2460-2468.
34. van der Helm-van Mil A.H., le Cessie S., van Dongen H., et al. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 2007, 56:433-440.
35. Trifiro G., Morabito P., Cavagna L., et al. Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study. Ann Rheum Dis 2013, 72:694-700.
36. Park Y.B., Park Y.S., Lee S.C., et al. Clinical analysis of gouty patients with normouricaemia at diagnosis. Ann Rheum Dis 2003, 62:90-92.
37. Urano W., Yamanaka H., Tsutani H., et al. The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis. J Rheumatol 2002, 29:1950-1953.
38. Pal B., Foxall M., Dysart T., et al. How is gout managed in primary care? A review of current practice and proposed guidelines. Clin Rheumatol 2000, 19:21-25.
39. Lumbreras B., Pascual E., Frasquet J., et al. Analysis for crystals in synovial fluid: training of the analysts results in high consistency. Ann Rheum Dis 2005, 64:612-615.
40. Rome K., Survepalli D., Sanders A., et al. Functional and biomechanical characteristics of foot disease in chronic gout: a case-control study. Clin Biomech (Bristol, Avon) 2011, 26:90-94.